Bi Xie
StarDioscorea hypoglauca Palibin
Traditionally used for
- Urinary & fluids
- Pain & joints
- Skin
☯ TCM Properties
Separates the Clear from the Turbid; Drains Dampness and Resolves Turbidity; Dispels Wind-Dampness; Relieves Painful Obstruction; Clears Damp-Heat from the Skin
Traditional Chinese Uses
Bi Xie (dioscorea hypoglauca rhizome) is a bitter, neutral herb used in Chinese medicine primarily to separate turbidity from clarity in the urinary system — addressing cloudy, turbid urine and urinary discomfort from Damp-Heat or Damp-Cold in the Bladder. Its damp-clearing action also extends to joint conditions with heaviness and stiffness from Dampness, and to weeping skin conditions like eczema from Damp obstruction. It is often described as the body's fluid-separating herb.
Western Herbalism Properties
Relationships
Full-screen graph →Click a node for details · double-click to expand it · Ctrl/⌘ + scroll or two fingers to zoom and pan.
Botanical Description
Dioscorea hypoglauca (and several closely related species treated together pharmaceutically), source of Bi Xie, is a perennial twining vine in the Dioscoreaceae family, native to central and southern China. The slender herbaceous stems climb 1-5 m from a stout, hard, woody, irregularly branched rhizome that runs horizontally near the soil surface. Leaves are alternate, broadly cordate to triangular-ovate, 5-15 cm long, palmately veined with 7-9 main veins from the heart-shaped base and an acuminate tip; lower surfaces are glaucous. Small unisexual flowers are borne in axillary spikes or panicles, the females producing three-winged dehiscent capsules. Rhizomes are dug in autumn and winter, sliced and dried.
Active Constituents
Protodioscin
Steroidal saponin (furostanol glycoside)Concentration: One of nine common HPLC fingerprint peaks in Dioscoreae Hypoglaucae Rhizoma; one of four saponins that discriminate this drug from Dioscoreae Spongiosae Rhizoma
Protodioscin is both a quality marker and one of the principal xanthine oxidase inhibitors identified in the rhizome by spectrum-effect analysis with molecular docking confirmation. Its abundance is one of the chemical differences that separate Fen Bi Xie from Mian Bi Xie, so a fingerprint that shows the wrong protodioscin peak is showing a different drug.
Methylprotodioscin
Steroidal saponin (furostanol glycoside)Concentration: Detected in Dioscoreae Hypoglaucae Rhizoma by HPLC fingerprinting
Identified alongside protodioscin, protogracillin and pseudoprogracillin as one of the four compounds most strongly correlated with xanthine oxidase inhibitory activity in the crude drug, and confirmed by direct enzyme assay and docking. It is one of the better-studied single constituents of this genus but has no human data.
Dioscin
Steroidal saponin (spirostanol glycoside)Concentration: Identified in Dioscoreae Hypoglaucae Rhizoma by UPLC-Q/TOF-MS; a discriminating fingerprint marker between the two Bi Xie drugs
Dioscin is poorly soluble and poorly absorbed, and the antihyperuricaemic effect attributed to it appears to be carried by its metabolites: in rodent models tigogenin inhibited urate reabsorption through URAT1 at 10-100 micromolar, while diosgenin and tigogenin promoted urate efflux through ABCG2. Note that this work used Dioscorea spongiosa, the Mian Bi Xie drug, not D. hypoglauca.
Gracillin
Steroidal saponin (spirostanol glycoside)Concentration: Identified by UPLC-Q/TOF-MS; one of the four chemometric markers separating the two Bi Xie drugs
A spirostanol saponin closely related to dioscin and, like it, more useful as an identity marker than as a characterised pharmacological principle. It sits in the saponin fraction that carries the drug's anti-inflammatory activity in cell models.
Protogracillin
Steroidal saponin (furostanol glycoside)Concentration: Identified by UPLC-Q/TOF-MS; a chemometric discriminator between the two Bi Xie drugs
Both a species marker and one of the four candidate xanthine oxidase inhibitors identified by spectrum-effect relationship analysis. Furostanol saponins such as this convert to their spirostanol counterparts on processing and storage, so the ratio in a given lot depends on how it was handled.
Pseudoprotodioscin
Steroidal saponin (furostanol glycoside)Concentration: Identified in Dioscoreae Hypoglaucae Rhizoma by UPLC-Q/TOF-MS
One of the six steroidal saponins characterised in the rhizome. It is reported to suppress SREBP-mediated cholesterol and triglyceride synthesis gene expression in cell work, which is a preclinical observation and not a lipid-lowering indication.
Total steroidal saponins
Steroidal saponin fractionConcentration: 6.93 +/- 0.01% of the crude rhizome extract, enriched 5.78-fold to 40.07 +/- 2.63% on HPD-100 macroporous resin
The saponin fraction is the drug's principal active fraction. Purified saponins showed better anti-inflammatory activity than the crude extract in LPS-stimulated RAW264.7 macrophages, which supports the fraction as the active one but says nothing about oral dosing in people.
Diarylheptanoids and lignans
Phenolic constituentsConcentration: Reported as secondary constituent classes of Bi Xie alongside the dominant steroidal saponins
These are the minor chemistry of the drug and are poorly characterised. Chinese reviews of Bi Xie note them as present but attribute the recorded anti-hyperuricaemic, anti-inflammatory, analgesic and anti-osteoporotic activities to the steroidal saponins.
⚠ Drug Interactions
Mian Bi Xie (Dioscorea spongiosa and Dioscorea futschauensis)
Bi Xie is not one drug. The Chinese Pharmacopoeia carries two: Fen Bi Xie, Dioscoreae Hypoglaucae Rhizoma, from Dioscorea hypoglauca, grown mainly in Zhejiang, Anhui, Jiangxi and Hunan; and Mian Bi Xie, Dioscoreae Spongiosae Rhizoma, from D. spongiosa and D. futschauensis, grown mainly in Zhejiang and Fujian. They are chemically distinguishable: hierarchical clustering, PCA and OPLS-DA on HPLC fingerprints separate them cleanly on protodioscin, protogracillin, dioscin and gracillin. Chinese reviews describe the botanical sources of Bi Xie as miscellaneous and the traded varieties as chaotic, with quality assessment lagging. Much of the pharmacology attributed to Bi Xie, including the best urate-excretion work, was actually done on D. spongiosa.
Clinical note: Specify which Bi Xie you are prescribing and check that the supplier does too. Do not carry evidence generated on D. spongiosa across to D. hypoglauca without saying so. Where the intent is the antihyperuricaemic action, note that the animal data sit with Mian Bi Xie.
Xanthine oxidase inhibitors (allopurinol, febuxostat)
Both pharmacopoeial Bi Xie drugs inhibit xanthine oxidase in vitro, and spectrum-effect analysis with Pearson correlation and partial least squares regression across nine fingerprint peaks attributed the activity to protodioscin, protogracillin, methylprotodioscin and pseudoprogracillin, each then confirmed by direct enzyme assay and molecular docking. This is the same enzyme allopurinol and febuxostat inhibit, so the effects are pharmacodynamically additive in principle. There is no human pharmacokinetic or interaction study, and in vitro enzyme inhibition by a poorly absorbed saponin does not establish a clinically meaningful dose.
Clinical note: If Bi Xie is used in a patient on allopurinol or febuxostat, check serum urate before and after starting rather than assuming no effect. Watch for mobilisation flares when urate falls rapidly, and do not reduce the conventional drug on the assumption the herb is covering the gap.
Uricosurics (probenecid, benzbromarone, lesinurad)
In potassium oxonate hyperuricaemia models, oral dioscin lowered serum urate, increased fractional excretion of uric acid and reduced renal lesions, downregulating renal GLUT-9 and upregulating OAT-1. The mechanism was traced to metabolites rather than dioscin itself: tigogenin inhibited urate reabsorption via URAT1 at 10-100 micromolar, and diosgenin and tigogenin promoted excretion via ABCG2. URAT1 is exactly the transporter benzbromarone and lesinurad block, so the actions overlap. This was animal and cell work using Dioscorea spongiosa, not D. hypoglauca.
Clinical note: Adding Bi Xie to a uricosuric without monitoring is unwise, particularly in a patient with reduced renal function or a stone history, where increased urinary urate load is the hazard. Maintain fluid intake and check renal function and urinary urate if both are used.
Dioscorea bulbifera (Huang Yao Zi)
This is an identity hazard within the genus rather than a documented substitution for Bi Xie. Dioscorea bulbifera, traded in Chinese medicine as Huang Yao Zi, contains furanoid clerodane diterpenoids, notably diosbulbin B and 8-epidiosbulbin E acetate, that cause hepatotoxicity, with reported nephrotoxicity, cardiotoxicity and thyroid effects as well. Bi Xie carries no such diterpenoid liability; the risk is entirely one of a Dioscorea rhizome being dispensed under the wrong name. Chinese reviews already describe the Bi Xie trade as varietally confused.
Clinical note: Buy Bi Xie from a supplier that identifies the botanical source, and investigate any transaminase rise in a patient taking a Dioscorea preparation rather than attributing it to the formula as a whole.
Dosage
| Form | Amount | Frequency | Duration | Population | Notes |
|---|---|---|---|---|---|
| decoction | 9–15 g | Daily | — | — | 中国药典 2020 monograph 【粉萆薢】【用法与用量】9～15g。 【性味与归经】苦，平。归肾、胃经。 — Matched by hand: Dioscorea hypoglauca is ChP 粉萆薢 (the other ChP 萆薢 is 绵萆薢, D. septemloba). Chinese Pharmacopoeia 2020, quoted verbatim. |
Evidence Tier
Strong evidence · 4 studiesRecorded studies by study design, strongest design at the top. This is a study-design tier only, not a GRADE rating: it does not weigh risk of bias, consistency or precision.
Systematic review / meta-analysis
1
1 verified · 0 unverified
Randomized controlled trial
0
Other clinical trial
0
Observational / case report
0
In vitro / animal
3
1 verified · 2 unverified
Show 3 studies
- Chemical Comparison and Identification of Xanthine Oxidase Inhibitors of Dioscoreae Hypoglaucae Rhizoma and Dioscoreae Spongiosae Rhizoma by Chemometric Analysis and Spectrum-Effect Relationship
- Effect and mechanism of dioscin from Dioscorea spongiosa on uric acid excretion in animal model of hyperuricemia
- Purification of steroidal saponins from dioscoreae hypoglaucae rhizoma by macroporous resin and evaluation of their anti-inflammatory effect
Other / unclassified
0
Verified: design read from PubMed for a DOI that resolves to the cited paper Unverified: taken from the study's recorded description
Clinical Studies
Chemical Comparison and Identification of Xanthine Oxidase Inhibitors of Dioscoreae Hypoglaucae Rhizoma and Dioscoreae Spongiosae Rhizoma by Chemometric Analysis and Spectrum-Effect Relationship
The key paper for the species question. HPLC fingerprints of Dioscoreae Hypoglaucae Rhizoma and Dioscoreae Spongiosae Rhizoma samples yielded nine common peaks; hierarchical clustering, principal component analysis and OPLS-DA separated the two drugs on protodioscin, protogracillin, dioscin and gracillin. Xanthine oxidase inhibition was measured in vitro and spectrum-effect analysis identified protodioscin, protogracillin, methyl protodioscin and pseudoprogracillin as the active constituents, confirmed by enzyme assay and docking. Two drugs, one pinyin name, different chemistry.
Effect and mechanism of dioscin from Dioscorea spongiosa on uric acid excretion in animal model of hyperuricemia
Oral dioscin at 25 and 50 mg/kg lowered serum urate over four hours in potassium oxonate hyperuricaemic rats, and two weeks of treatment in adenine-oxonate mice lowered serum urate and creatinine, raised urate and creatinine clearance and fractional urate excretion, and reduced renal lesions, with renal GLUT-9 downregulated and OAT-1 upregulated. The active species in vivo was the metabolite tigogenin, which inhibited URAT1-mediated reabsorption at 10-100 micromolar; diosgenin and tigogenin increased excretion via ABCG2. The source plant was Dioscorea spongiosa, the Mian Bi Xie drug, not D. hypoglauca.
Purification of steroidal saponins from dioscoreae hypoglaucae rhizoma by macroporous resin and evaluation of their anti-inflammatory effect
Work on the correct species. UPLC-Q/TOF-MS identified six steroidal saponins in Dioscorea hypoglauca rhizome: protodioscin, protogracillin, pseudoprotodioscin, pseudoprotogracillin, dioscin and gracillin. HPD-100 macroporous resin raised saponin purity 5.78-fold, from 6.93% to 40.07% of the extract, and the purified saponin fraction was more anti-inflammatory than the crude extract in LPS-stimulated RAW264.7 macrophages. This locates the activity in the saponin fraction but is entirely a cell model.
Bixie Fenqing decoction in the treatment of chronic prostatitis: A systematic review and meta-analysis
A meta-analysis of randomised trials of Bixie Fenqing decoction in 1104 patients with chronic prostatitis, searching Chinese and international databases to March 2024. It reports improved total effective rate (RR 1.20, 95% CI 1.13-1.26) and cure rate (RR 1.52, 95% CI 1.24-1.86), lower NIH-CPSI total scores (MD -4.41, 95% CI -5.27 to -3.55) and lower prostatic fluid TNF-alpha and leucocyte counts. This is evidence for the multi-herb formula, not for Bi Xie as a single drug, the included trials are almost entirely Chinese-language with the risk-of-bias limitations typical of that literature, and the formula's source species is generally not specified.
Historical Texts
Shen Nong Ben Cao Jing (Divine Husbandman's Classic of the Materia Medica)
Han dynasty, compiled c. 200 CEYang Shi Jia Cang Fang (Yang's Family Treasured Formulas), Yang Tan
Southern Song dynasty, 1178Yi Xue Xin Wu (Medical Revelations), Cheng Guopeng
Qing dynasty, 1732Pharmacopoeia of the People's Republic of China
Current editions, including 2020References
- Chen C, Zeng CH, Zhang SQ, Wei L. [Research progress of Bixie]. . Zhongguo Zhong Yao Za Zhi (China Journal of Chinese Materia Medica) (2017) [DOI]
- Mathew E, Thomas PL, Mathew L. Dioscorea bulbifera: Phytotherapeutic Potential and Toxicological Risks, A Critical Review . Planta Medica (2025) [DOI]
- Chinese Pharmacopoeia Commission. Pharmacopoeia of the People's Republic of China, 2020 Edition, Volume I . China Medical Science Press, Beijing (2020)
This information is for educational purposes only and is not intended to replace professional medical advice. Always consult a qualified healthcare provider before using any herbal remedy, especially if you are pregnant, nursing, or taking medications.
📝 Notes
Public notes from the community and your own private notes on Bi Xie.
No notes yet.